DermorphinSpecialtySafety Rating 3/10

Primary research areaPain management (research)

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose rangeResearch compound only. Animal studies: 10–100 mcg/kg. Human dosing not established.
AdministrationVaries
Safety3/10 · Not FDA-approved
NCAA D1Banned

Price Comparison

Compare vendors · per 5mg

3 vendors competing

VendorPrice$ / mgUpdated
LeoLab RxBest $/mgCOA ✓ · 3P$30.00$6.00Apr 6, 2026Buy →
Behemoth LabzCOA ✓ · 3P$146.97$14.70May 14, 2026Buy →
PureRawzCOA ✓ · 3P$147.26$14.73May 14, 2026Buy →

Overview

About Dermorphin

Mechanism of action

Natural heptapeptide from frog skin; potent μ-opioid receptor agonist (30–40x more potent than morphine); D-amino acid backbone provides metabolic stability.

Safety profile

Opioid side effects: respiratory depression, dependence, tolerance, constipation, sedation. High abuse potential. Not for human therapeutic use. · Potent mu-opioid agonist; respiratory depression risk; used illegally in horse racing; proven opioid dangers

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Dermorphin

Failed to fetch